Non-structural protein NS1 of influenza A viruses interacts with cellular factors through its Nterminal RNA-binding, middle effector and C-terminal non-structured domains. NS1 attenuates antiviral responses in infected cells and thereby secures efficient virus replication. Some influenza strains express C-terminally truncated NS1 proteins due to nonsense mutations in the NS1 gene. To understand the role of the NS1 C-terminal region in regulation of antiviral responses, we engineered influenza viruses expressing C-terminally truncated NS1 proteins using A/WSN/33(H1N1) reverse genetics and tested them in human macrophages and in mice. We showed that a WSN virus expressing NS1 with a 28 aa deletion from its C terminus is a more powerful inducer of antiviral responses than the virus expressing full-length NS1, or one with a 10 aa truncation of NS1 in vitro. Thus, our findings suggest that the C-terminal region of NS1 is essential for regulation of antiviral responses. Moreover, viruses expressing truncated NS1 proteins could be good vaccine candidates.
Human influenza A viruses mutate rapidly and cause seasonal epidemics and occasional pandemics, imposing a constant health threat and economic burden. Influenza A viruses belong to the family Orthomyxoviridae and have segmented ssRNA genomes, which encode haemagglutinin (HA), neuraminidase (NA), nucleoprotein (NP), matrix proteins (M1 and M2), non-structural protein (NS1), nuclear export protein (NS2), polymerase subunits (PA, PB1 and PB2) and auxiliary proteins, such as PA-X and PB1-F2. The influenza A virus genome is protected by NP and polymerase subunits, which together form viral ribonucleoprotein particles (vRNPs) . The vRNPs are encapsulated in an M1 shell. The shell is surrounded by a lipid bilayer. HA, NA and M2 are embedded in the lipid bilayer. Upon infection, influenza A viruses express the NS1 proteins, which antagonize antiviral responses to ensure efficient virus replication (Müller et al., 2012; Ayllon and García-Sastre, 2015; Hale et al., 2008) .
Human influenza A viruses are classified into subtypes based on the structures of HA and NA (e.g. H1N1, H3N2, H2N2). Influenza strains of the H1N1 subtype caused two global influenza pandemics ('Spanish flu' in 1918 and 'swine flu' in 2009 ) and many influenza epidemics (http://www.cdc.gov).
Analysis of available influenza A/H1N1 viral genomes revealed that the viruses sporadically acquire nonsense and missense mutations, which result in truncations or extensions of the C terminus of the viral NS1 protein ( Fig. 1a ) (Dundon and Capua, 2009; Jalovaara et al., 2014; Lakspere et al., 2014) . It was shown that truncations and extensions of the C terminus of viral NS1 could modulate virus pathogenicity Kong et al., 2015; Soubies et al., 2010) .
To address a possible role of the NS1 C terminus in regulation of antiviral responses, we generated two viruses (WSN-220 and WSN-202) expressing C-terminally truncated NS1 proteins using the reverse genetics system of A/WSN/ 33(H1N1) (Hoffmann et al., 2000) , as well as a Phusion site-directed mutagenesis kit (Life Technologies) and specific primer pairs [59-(Pho)AGATTCGCTTGAAGAAG and 59-(Pho)CTGTAGAGTTTCAGAGACT to generate the WSN-202 virus, and 59-(Pho)AATTAGGTCAGAAGTTTGAAGA and 59-(Pho)GTTCCCGCCATTTACCGTTT to generate the WSN-220 virus] ( Fig. 1b ). We also reconstituted WT virus (WSN-230) expressing full-length NS1. The A/WSN/ 33(H1N1) strain was chosen because it is probably the best characterized cell-culture-and mouse-adapted A/H1N1 strain, and it is genetically more stable than A/H1N1pdm09 viruses (Jalovaara et al., 2014) . The positions of nonsense mutations were chosen based on the sequence alignments of NS1 C-terminal regions. In particular, WSN-220 virus was designed to express NS1 lacking the PDZ-binding domain, and WSN-202 virus was designed to express NS1 lacking the PDZ-binding domain, as well as phosphorylation, SUMOylation and ISGylation sites ( Fig. 1b ). It should be noted that nonsense mutations introduced into NS1 RNA did not affect the sequence of NS2 RNA, which is expressed from the same viral genetic segment as NS1.
We assembled recombinant WSN-202, WSN-220 and WT WSN-230 viruses in HEK cells and propagated them in Vero cells. We obtained similar titres for all three viruses and observed similar plaque morphologies in a plaque assay on MDCK cells ( Fig. 1c ). We infected MDCK cells with WSN-202, WSN-220 or WSN-230 viruses at an m.o.i. of 0.01 following the procedure described by Denisova et al. (2012) . We found that WSN-202, WSN-220 and WSN-230 viruses replicated efficiently in MDCK cells ( Fig. 1d ).
Human monocyte-derived macrophages serve as an excellent cellular model for studying antiviral responses, because alveolar macrophages represent primary targets for influenza virus infection (Denisova et al., 2012) . Therefore, we used monocyte-derived macrophages in our next experiments. We infected human monocyte-derived macrophages with WSN-202, WSN-220 or WSN-230 viruses at an m.o.i. of 0.01. Quantitative RT-PCR analysis of NS1 RNA suggested that similar quantities of viral RNA were produced, and similar quantities of virus particles were released into culture medium, from macrophages infected with WSN-202, WSN-220 or WSN-230 virus at 48 h post-infection (p.i.) ( Fig. 1e , f). Western blot analysis revealed that NP proteins of three viruses were efficiently translated in infected macrophages ( Fig. 1g ). Please note that we were unable to demonstrate similar expression levels of NS1 during replication of WSN-202, WSN-220 and WSN-230 by Western blotting, most likely due to different affinities of the anti-NS1 antibody to NS1 proteins of different lengths.
To monitor the effect of NS1 C-terminal truncations on antiviral responses, we infected macrophages with WSN-202, WSN-220 or WSN-230 virus at an m.o.i. of 2. After 8 h, we extracted total RNA and analysed expression of cellular genes as described previously (Denisova et al., 2014) . WSN-230, WSN-220 and WSN-202 viruses induced expression of 94, 110 and 158 cellular genes, respectively, compared with non-infected cells ( Fig. 2a, b) . Importantly, the majority of differentially expressed genes are involved in antiviral responses (e.g. MX1, MX2, ISG15, IFIT1, IFIT2, OASL, CCL8, CXCL10, IL6 and IL8). We concluded that the C-terminal region of NS1 can modulate expression of immune-related genes in infected cells.
We next analysed cytokine production by infected macrophages following procedures described by Denisova et al. (2014) . The WSN-202 and WSN-220 viruses enhanced production of IL-6 and IL-8 in comparison with WSN-230 ( Fig. 2c ). However, CCL4 levels were lower in the medium of WSN-202-and WSN-220-infected cells. These results indicate that the C-terminal region of NS1 affects cytokine production in infected cells.
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We challenged female BALB/c mice with WSN-202, WSN-230 or mock infections (six mice per group) following a published procedure (Kakkola et al., 2013) . Mice infected with WSN-202 experienced only moderate weight loss and completely recovered from infection, in contrast to WSN-230infected mice (Fig. 3a, b) . We next performed another experiment in which we infected female BALB/c mice with WSN-202, WSN-230 or mock (six mice per group), and at day 3 p.i., we sacrificed the mice and collected the lungs. Lungs were homogenized, and virus titres and cytokine levels were measured as described previously (Kakkola et al., 2013) .
We found significantly lower viral loads in the lungs of WSN-202-infected mice in contrast to WSN-230-infected animals, indicating that C-terminal truncation of NS1 attenuates replication of influenza WSN virus in mice (Fig. 3c ).
We also observed a significant imbalance in cytokine production in WSN-202-infected mice in comparison with WSN-230-infected mice (Fig. 3d ). This imbalance probably resulted from an ability of the immune system to clear the virus, eventually leading to recovery of the WSN-202infected animals. These results indicate that the NS1 C terminus regulates antiviral responses and contributes to virus pathogenicity in infected mice.
Thus, our results suggest that the NS1 C terminus regulates antiviral responses in infected human macrophages and mice. Our results support previous studies, which demonstrated that not only functional motifs but also the physical length of the NS1 C terminus region modulates virus replication and pathogenicity Kong et al., 2015; Soubies et al., 2010) .
The C-terminal region of NS1 accommodates or eliminates functional motifs involved in virus-host interplay and thereby provides evolutional plasticity for influenza A viruses. This viral property could be utilized to improve the efficacy of live-attenuated influenza vaccines, i.e. naturally occurring or genetically engineered influenza strains that encode NS1 with altered C-terminal regions could be used as vaccine candidates (Richt and García-Sastre, 2009 ).
